This Health Industry Insights NewsFlash examines Intel Corp.'s announcement made on July 10, that it had received approval of its application for a 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for its first personal health system, the Intel Health Guide (IHG).

Intel has completed pilot studies in the United States and United Kingdom. In late 3Q08, Intel plans to conduct additional pilot studies with healthcare organizations to understand how the IHG integrates with different care management models in the home and expects it to be commercially available in the United States and United Kingdom in late 4Q08 or early 1Q09.

Related Reports:
Testing Laboratories
Collaboration Cubed: Industry, Government, and Academia Working Together to Improve Health
Japanese Market for Women's Health Devices 2009
U.S. Market for Emergency Patient Tracking Systems (EPTS)
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
2009 Worldwide Diagnostics Market Research Bundle
Patient Monitoring Markets
Laboratory Corporation of America Holdings
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Laboratory Information Management Systems